IMMCO DIAGNOSTICS, INC.
- Shared products
- ANTIBODY ANTI-EXTRACTABLE NUCLEAR ANTIGENS (ENA), ANTIBODY FOR CELIAC DISEASE, ANTICARDIOLIPIN, ANTICORPO ANTICITOPLASMÁTICO, ANTICORPO ANTINUCLEAR (ANA), ANTICORPO PARA DOENÇA CELÍACA, ANTICYTOPLASMIC ANTIBODY, ANTINUCLEAR ANTIBODY (ANA), ANTIPHOSPHOLIPID ANTIBODY, PARIETAL CELL ANTIBODY
- Shared products
- ANTI-ASCA ANTIBODY, ANTIBODY ANTI-EXTRACTABLE NUCLEAR ANTIGENS (ENA), ANTIBODY FOR CELIAC DISEASE, ANTICARDIOLIPIN, ANTICORPO ANTI-ANTÍGENOS NUCLEARES EXTRAÍVEIS (ENA), ANTICYTOPLASMIC ANTIBODY, ANTINUCLEAR ANTIBODY (ANA), ANTIPHOSPHOLIPID ANTIBODY, PARIETAL CELL ANTIBODY
- Shared products
- ANTI-ASCA ANTIBODY, ANTIBODY ANTI-EXTRACTABLE NUCLEAR ANTIGENS (ENA), ANTIBODY FOR CELIAC DISEASE, ANTICARDIOLIPIN, ANTICYTOPLASMIC ANTIBODY, ANTINUCLEAR ANTIBODY (ANA), ANTIPHOSPHOLIPID ANTIBODY, PARIETAL CELL ANTIBODY
- Shared products
- ANTI-ASCA ANTIBODY, ANTIBODY ANTI-EXTRACTABLE NUCLEAR ANTIGENS (ENA), ANTIBODY FOR CELIAC DISEASE, ANTICARDIOLIPIN, ANTICYTOPLASMIC ANTIBODY, ANTINUCLEAR ANTIBODY (ANA), ANTIPHOSPHOLIPID ANTIBODY
- Shared products
- ANTIBODY ANTI-EXTRACTABLE NUCLEAR ANTIGENS (ENA), ANTIBODY FOR CELIAC DISEASE, ANTICARDIOLIPIN, ANTICYTOPLASMIC ANTIBODY, ANTINUCLEAR ANTIBODY (ANA), ANTIPHOSPHOLIPID ANTIBODY
Explore comprehensive manufacturer profile for IMMCO DIAGNOSTICS, INC. based in United States through Pure Global AI's free Brazil medical device database. This manufacturer has 29 products registered with ANVISA across 8 unique technical categories. Their regulatory history spans from Apr 15, 2019 to Jun 03, 2019.
This page provides detailed insights including 5 recent product registrations including ANTIBODY FOR CELIAC DISEASE, 5 most popular products with ANTICYTOPLASMIC ANTIBODY having 7 registrations, 1 registration holders including TRINITY BIOTECH DO BRASIL COMÉRCIO E IMPORTAÇÃO LTDA., and 5 key competitors with INOVA DIAGNOSTICS, INC. sharing 10 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.